Journal of Clinical Pathways March 16, 2021
Winston Wong, PharmD

Machine learning, artificial intelligence, immunotherapy, genomics, robotic limbs, wearable health-monitoring tech, mRNA vaccines—it is an exciting time in medical research and technology. Yet, we must be mindful that such advances may require a rethinking or reengineering of our underlying infrastructures to integrate new tools, therapies, and programs effectively. Discovering and addressing gaps in our processes and systems will require continued and enhanced collaboration among stakeholders so that all patients can benefit from the latest advances in medicine and technology. The articles in this issue focus on the need for continued care coordination to ensure access to CAR-T therapy, the role of electronic consultations (eConsults) in care, and how pathways
programs are continuing to evolve—clinically and technologically.

Advances in cellular bioengineering are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Digital Health, Pharma / Biotech, Provider, Technology, Wearables
Epic's new interoperability push, explained
Your Earphones And Headphones As Health And Medical Devices
277 million patients' data drives Epic's research findings
Google digs deeper into healthcare AI: 5 notes
Wearable Devices for Parkinson’s Disease: The Future Is Here

Share This Article